85 FR 169 pgs. 53822-53823 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
Type: NOTICEVolume: 85Number: 169Pages: 53822 - 53823
Pages: 53822, 53823Docket number: [Docket Nos. FDA-2019-N-3657; FDA-2019-N-6085; FDA-2017-N-6381; FDA-2017-N-0084; FDA-2013-N-0731; FDA-2019-N-5971; FDA-2014-N-1021; and FDA-2019-N-3018]
FR document: [FR Doc. 2020-19092 Filed 8-28-20; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2019-N-3657; FDA-2019-N-6085; FDA-2017-N-6381; FDA-2017-N-0084; FDA-2013-N-0731; FDA-2019-N-5971; FDA-2014-N-1021; and FDA-2019-N-3018]
Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
[top]
| Title of collection | OMB control number | Date approval expires |
|---|---|---|
| Accreditation Scheme for Conformity Assessment Pilot Program | 0910-0889 | 6/30/2023 |
| General Administrative Practice and Procedures | 0910-0191 | 7/31/2023 |
| Records and Reports Concerning Experience With Approved New Animal Drugs | 0910-0284 | 7/31/2023 |
| Adverse Event Program for Medical Devices (Medical Product Safety Network | 0910-0471 | 7/31/2023 |
| Human Cells, Tissues, and Cellular and Tissue-Based Products: Establishment Registration and Listing; Eligibility Determination for Donors; and Current Good Tissue Practice | 0910-0543 | 7/31/2023 |
| Recommendations to Reduce the Risk of Transfusion-Transmitted of Infection in Whole Blood and Blood Components; Agency Guidance | 0910-0681 | 7/31/2023 |
| Food Labeling; Gluten-Free Labeling of Fermented or Hydrolyzed Foods | 0910-0817 | 8/31/2023 |
| Healthcare Provider Perception of Boxed Warning Information Survey | 0910-0890 | 8/31/2023 |
Dated: August 24, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-19092 Filed 8-28-20; 8:45 am]
BILLING CODE 4164-01-P